Cognitive Impairments Clinical Trial
Official title:
Attention & Memory Impairments in Menopausal Women: A Possible Role for Vyvanse?
The purpose of this study is to determine whether a medication called Vyvanse® (lisdexamfetamine; LDX) has an impact on cognitive functioning, specifically measures of sustained attention, verbal encoding and recall and working memory, in menopausal aged women. LDX is a medication used to treat attention deficit hyperactivity disorder (ADHD). The cognitive difficulties that menopausal women report experiencing are typical of adults who are diagnosed with ADHD. The investigators will assess whether or not LDX is effective in alleviating those cognitive disruptions when compared to a placebo.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04470219 -
Digital Support for People With Cognitive Impairment
|
N/A | |
| Completed |
NCT01071044 -
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
|
Phase 4 | |
| Completed |
NCT02962687 -
Video-Enhanced Care Management for Medically Complex Veterans
|
N/A | |
| Recruiting |
NCT05053204 -
Influence Factors and Cognitive Characteristics in Unipolar and Bipolar Depression:Based on the THINC-it Tool
|
||
| Recruiting |
NCT02778581 -
Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment
|
N/A | |
| Suspended |
NCT00197483 -
Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia
|
Phase 2 | |
| Completed |
NCT05585424 -
Effectiveness of a Program Based on Observation-action Training (AOT) in Patients With Cognitive Impairment.
|
N/A | |
| Completed |
NCT05822596 -
Tablet-based Interactive Games in Elderly With Cognitive Impairment and Persons With Intellectual Disability
|
N/A | |
| Completed |
NCT02830854 -
Molecular Hydrogen for Cognitive Function and Performance in Elderly
|
Phase 3 | |
| Withdrawn |
NCT01986777 -
LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy
|
N/A | |
| Recruiting |
NCT01466205 -
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
|
Phase 2 | |
| Recruiting |
NCT05896189 -
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
|
N/A | |
| Not yet recruiting |
NCT06212726 -
RTL Concussion Communication
|
N/A | |
| Completed |
NCT02868684 -
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
|
||
| Recruiting |
NCT04490330 -
Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients
|
||
| Completed |
NCT02677987 -
The "Light for the Brain" Study
|
N/A | |
| Completed |
NCT02746484 -
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program
|
N/A |